---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-017476"
form_type: "8-K"
ticker: "RNTX"
cik: "0001420565"
company_name: "Rein Therapeutics, Inc."
filed_at: "2024-01-29T23:59:59+00:00"
generated_at: "2026-06-06T15:50:03.763219+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aileron sets deadlines for shareholder proposals and director nominations for Feb 2024 annual meeting

## Summary
- Annual meeting scheduled for February 28, 2024; no 2023 meeting was held.
- Deadline for Rule 14a-8 stockholder proposals: January 29, 2024.
- Deadline for director nominations under bylaws: February 8, 2024.
- Submission address: 738 Main Street #398, Waltham, MA 02451.

## SEC filing metadata
- accession: 0001193125-24-017476
- form_type: 8-K
- ticker: RNTX
- cik: 0001420565
- company_name: Rein Therapeutics, Inc.
- filed_at: 2024-01-29T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420565/000119312524017476/0001193125-24-017476-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420565/000119312524017476/d103474d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-017476
- JSON: https://secwatch.observer/filing/0001193125-24-017476.json
- Plain text: https://secwatch.observer/filing/0001193125-24-017476.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.